Kline J A, Leonova E, Raymond R M
Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC 28232-2861, USA.
Crit Care Med. 1995 Jul;23(7):1251-63. doi: 10.1097/00003246-199507000-00016.
Myocardial depression from verapamil toxicity may result from alterations in carbohydrate metabolism as well as calcium-channel antagonism. We hypothesized that pharmacologic doses of insulin may be effective in reversing both of these deficits.
Randomized, controlled, prospective study.
Laboratory of an urban hospital.
Thirty mongrel dogs.
Thirty mongrel canines were anesthetized with alpha-chloralose. Toxicity was induced by the administration of 0.1 mg/kg/min iv of verapamil, until there was a 50% reduction in mean arterial pressure, for 30 mins (titration), followed by a continuous verapamil infusion of 1 mg/kg/hr. Animals (n = 6 per group) were randomized to the control group (saline only) or to one of four treatment protocols: a) calcium chloride (20 mg/kg), then 0.6 mg/kg/hr; b) hyperinsulinemia-euglycemia (4.0 U/min of recombinant insulin, with arterial glucose concentration clamped to +/- 10 mg/dL [+/- 0.5 mmol/L] of the basal value); c) epinephrine, with a starting rate of 1.0 microgram/kg/min, titrated to maintain left ventricular pressure at basal values; or d) glucagon, a 0.2-mg/kg bolus, followed by a 150-microgram/kg/hr infusion. Animals were monitored until death or 240 mins; infusate volumes were held constant for all groups.
During verapamil titration, the myocardial respiratory quotient increased from 0.84 +/- 0.05 to 1.07 +/- 0.11 (p < .05, paired t-test) and myocardial glucose uptake doubled, despite a reduction in cardiac work (p < .05, paired t-test). Net myocardial lactate uptake also increased significantly, excluding myocardial ischemia. In controls, this trend continued, indicating preferential carbohydrate metabolism during untreated verapamil toxicity. Despite hyperglycemia, the plasma insulin concentration was not significantly different in controls (basal value 11 +/- 2 vs. 39 +/- 21 microU/mL at 30 mins). Hyperinsulinemia-euglycemia increased both myocardial glucose and lactate uptake five-fold, and significantly increased the ratio of myocardial oxygen delivery/work, along with superior improvements in maximal left ventricular elastance at end systole compared with other treatments (p < .05 vs. other treatments, contrast analysis).
Verapamil toxicity renders the heart dependent on carbohydrate metabolism. Inasmuch as the positive inotropic effects of all treatments were coincident with increased indices of myocardial carbohydrate uptake, adequate treatment of verapamil toxicity appeared to require maximal myocardial carbohydrate utilization. Hyperinsulinemia-euglycemia allows larger increases in myocardial carbohydrate metabolism and myocardial contractility than calcium chloride, epinephrine, or glucagon, resulting in improved survival rates during severe verapamil toxicity.
维拉帕米毒性导致的心肌抑制可能源于碳水化合物代谢改变以及钙通道拮抗作用。我们推测药理剂量的胰岛素可能有效逆转这两种缺陷。
随机、对照、前瞻性研究。
城市医院实验室。
30只杂种犬。
30只杂种犬用α-氯醛糖麻醉。通过静脉注射维拉帕米0.1mg/kg/min,持续30分钟(滴定),直至平均动脉压降低50%,随后以1mg/kg/hr的速度持续输注维拉帕米来诱导毒性。动物(每组6只)被随机分为对照组(仅给予生理盐水)或四种治疗方案之一:a)氯化钙(20mg/kg),然后0.6mg/kg/hr;b)高胰岛素-正常血糖(重组胰岛素4.0U/min,动脉血糖浓度维持在基础值的±10mg/dL[±0.5mmol/L]);c)肾上腺素,起始速率为1.0μg/kg/min,滴定以维持左心室压力在基础值;或d)胰高血糖素,0.2mg/kg静脉推注,随后以150μg/kg/hr输注。对动物进行监测直至死亡或240分钟;所有组的输注液体积保持恒定。
在维拉帕米滴定期间,心肌呼吸商从0.84±0.05增加到1.07±0.11(p<0.05,配对t检验),心肌葡萄糖摄取量增加一倍,尽管心脏做功减少(p<0.05,配对t检验)。心肌乳酸净摄取也显著增加,排除心肌缺血。在对照组中,这种趋势持续存在,表明在未治疗的维拉帕米毒性期间碳水化合物代谢占优势。尽管血糖升高,但对照组的血浆胰岛素浓度无显著差异(基础值11±2与30分钟时的39±21μU/mL)。高胰岛素-正常血糖使心肌葡萄糖和乳酸摄取增加五倍,并显著增加心肌氧输送/做功比值,与其他治疗相比,在收缩末期最大左心室弹性方面有更好的改善(与其他治疗相比p<0.05,对比分析)。
维拉帕米毒性使心脏依赖碳水化合物代谢。由于所有治疗的正性肌力作用都与心肌碳水化合物摄取指标增加一致,维拉帕米毒性的充分治疗似乎需要最大程度的心肌碳水化合物利用。高胰岛素-正常血糖比氯化钙、肾上腺素或胰高血糖素能使心肌碳水化合物代谢和心肌收缩力有更大增加,从而在严重维拉帕米毒性期间提高生存率。